EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The growing field of liquid biopsy and its Snowball effect on reshaping cancer management

Roberto Borea, Carolina Reduzzi

The Journal of Liquid Biopsy · 2025-06 · 8 · 100293

DOI: 10.1016/j.jlb.2025.100293 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Liquid Biopsy, 2025-06. Verfasst von Roberto Borea und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University Federico II of Naples, Naples, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy (LB) has emerged as a transformative tool in oncology, providing a minimally invasive approach for tumor detection, molecular characterization, and real-time treatment monitoring. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), and microRNA (miRNA), LB enables comprehensive tumor profiling without the need for traditional tissue biopsies. Over the past decade, research in this field has expanded exponentially, leading to the integration of LB into clinical practice for specific cancer types, including lung and breast cancer. In 2024, the Journal of Liquid Biopsy (JLB) published innovative studies exploring the latest advancements in LB technologies, biomarkers, and their applications for cancer detection, minimal residual disease (MRD) monitoring, and therapy response assessment. This review synthesizes recent findings on the role of LB in cancer treatment and monitoring across different biomarkers, with a particular focus on newly published studies and their context within translational research. Additionally, it highlights emerging techniques such as fragmentomics, artificial intelligence, and multiomics, paving the way for more precise, personalized treatment decisions. Despite these advancements, challenges remain in standardizing methodologies, optimizing clinical validation, and integrating LB into routine oncological workflows. This mini-review highlights the evolving landscape of LB research and its potential to revolutionize cancer diagnosis, treatment monitoring, and therapeutic decision-making, ushering in a new era of precision oncology.

Schlagwörter

Stichwörter der Autor:innen

Circulating tumor DNA/ctDNACirculating tumor cells/CTCsLiquid biopsyMicroRNA/miRNASolid tumors

Autor:innen und Institutionen

  • Department of Public Health, University Federico II of Naples, Naples, Italy.
  • Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Department of Medicine, Weill Cornell Medicine, Englander Institute for Precision Medicine, New York Presbyterian Hospital, New York, NY, 10021, USA.

Zitieren

APA

Borea, R., & Reduzzi, C. (2025). The growing field of liquid biopsy and its Snowball effect on reshaping cancer management. The Journal of Liquid Biopsy, 8, 100293. https://doi.org/10.1016/j.jlb.2025.100293

Vancouver

Borea R, Reduzzi C. The growing field of liquid biopsy and its Snowball effect on reshaping cancer management. The Journal of Liquid Biopsy. 2025;8:100293. doi:10.1016/j.jlb.2025.100293

BibTeX
@article{Borea2025,
  author = {Borea, Roberto and Reduzzi, Carolina},
  title = {The growing field of liquid biopsy and its Snowball effect on reshaping cancer management},
  journal = {The Journal of Liquid Biopsy},
  year = {2025},
  volume = {8},
  pages = {100293},
  doi = {10.1016/j.jlb.2025.100293}
}
Kostenlos starten →